The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ALKERMES PLC | COM | G01767105 | 26,055 | 1,572,395 | SH | SOLE | 1,572,395 | 0 | 0 | ||
| ALEXION PHARMACEUTICALS INC | COM | 015351109 | 45,380 | 396,575 | SH | SOLE | 396,575 | 0 | 0 | ||
| ANAPTYSBIO INC | COM | 032724106 | 1,753 | 118,858 | SH | SOLE | 118,858 | 0 | 0 | ||
| BIOGEN INC | COM | 09062X103 | 38,910 | 137,163 | SH | SOLE | 137,163 | 0 | 0 | ||
| ENANTA PHARMACEUTICALS INC | COM | 29251M106 | 37,784 | 825,329 | SH | SOLE | 825,329 | 0 | 0 | ||
| INVACARE CORP | COM | 461203101 | 6,625 | 880,920 | SH | SOLE | 880,920 | 0 | 0 | ||
| MCKESSON CORP | COM | 58155Q103 | 27,705 | 186,030 | SH | SOLE | 186,030 | 0 | 0 | ||
| REGENERON PHARMACEUTICALS | COM | 75886F107 | 46,046 | 82,258 | SH | SOLE | 82,258 | 0 | 0 | ||
| SURGALIGN HOLDINGS INC | COM | 86882C105 | 11,315 | 6,251,208 | SH | SOLE | 6,251,208 | 0 | 0 | ||
| TARO PHARMACEUTICAL INDUS | COM | M8737E108 | 29,475 | 537,378 | SH | SOLE | 537,378 | 0 | 0 | ||
| UNITED THERAPEUTICS CORP | COM | 91307C102 | 43,048 | 426,215 | SH | SOLE | 426,215 | 0 | 0 | ||